(2-chloropyridin-4-yl)(4-methylpiperazin-1-yl)methanone

Catalog No.: 
ACMGCE575
CAS No.: 
612487-28-2
Molecular Formula: 
C11H14ClN3O
Molecular Weight: 
239.71
(2-chloropyridin-4-yl)(4-methylpiperazin-1-yl)methanone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$217.001 week1 week

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2-chloropyridin-4-yl)(4-methylpiperazin-1-yl)methanone
IUPAC Name(2-chloropyridin-4-yl)(4-methylpiperazin-1-yl)methanone
Molecular FormulaC11H14ClN3O
Molecular Weight239.71
SMILESCN1CCN(C(=O)C2=CC(Cl)=NC=C2)CC1
InChI KeyOJSUZRNVWYHBNS-UHFFFAOYSA-N
Synonym1-(2-CHLOROISONICOTINOYL)-4-METHYLPIPERAZINE;1-(2-chloroisonicotinoyl)-4-methylpiperazine(SALTDATA: HCl);Methanone, (2-chloro-4-pyridinyl)(4-methyl-1-piperazinyl)-;(2-Chloropyridin-4-yl)(4-methylpiperazin-1-yl)methanone
CAS No.612487-28-2

Synthetic Route by SureRoute

1. ACMGCE575 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJACD865 route compound structure diagram
    ACJACD86534352-59-5In Stock
  2. Plus
  3. ACTUJC106 route compound structure diagram
    ACTUJC1066313-54-8In Stock
  4. Then
  5. ACMGCE575 route product structure diagram
    ACMGCE575612487-28-2
Inquiry

2. ACMGCE575 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJACD865 route compound structure diagram
    ACJACD86534352-59-5In Stock
  2. Plus
  3. ACCZJF509 route compound structure diagram
    ACCZJF50965287-34-5In Stock
  4. Then
  5. ACMGCE575 route product structure diagram
    ACMGCE575612487-28-2
Inquiry

3. ACMGCE575 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMGCE575 route product structure diagram
    ACMGCE575612487-28-2
Inquiry

Comments (0)